Tag: PK/PD Modeling & Simulation
Latest updates demonstrate commitment to customers and market leadership of Phoenix Platform PRINCETON, N.J.—June 24, 2020. Certara®, the global leader in biosimulation, today announced the launch of version 8.3 of its Phoenix™ platform, the industry gold standard in pharmacokinetic/ pharmacodynamic (PK/PD) and toxicokinetic modeling and simulation software. Version 8.3 delivers new features to drive efficiencies and … Continued
This webinar will explain lessons learned from preparing for and responding to viral outbreaks such as H5N1 and pH1N1 influenza and discuss how insights from model-informed drug development approaches can spur access to medicines for patients.
This webinar addressed some of the challenges associated with pediatric drug development and the advantages (and limitations) that pediatric population PK modeling can provide.
Certara uses a unique set of disciplines and technologies to address the challenges that infectious disease drug programs face.
This webinar showed how to use a time correction factor to establish a meaningful IVIVC for delayed release formulation drugs.